A pharmacokinetic study of adriamycin and 4′epi-adriamycin after simultaneous intra-arterial liver administration
Authors:
- 1 June 1986
- journal article
- research article
- Published by Springer Nature in Medical Oncology and Tumor Pharmacotherapy
- Vol. 3 (2) , 105-110
Abstract
The plasma pharmacokinetics of adriamycin and 4′epi-adriamycin were studied in patients with malignant tumors of the liver after simultaneous regional administration of equal amounts of the two anthracyclines by the arterial route. The use of a highly selective liquid chromatographic analytical method permitted quantification of plasma concentrations of the two drugs as well as their corresponding 13-hydroxy metabolites. The plasma concentrations of each drug followed a three-compartment open model. On average the area under the plasma concentration time curve (AUC) and the maximum plasma concentration (C max) were 2.1 and 1.7 times larger for adriamycin than for 4′epi-adriamycin, respectively. 4′Epi-adriamycin was eliminated faster than adriamycin, the terminal half-life time being on the average 1.5 times higher for adriamycin. These findings are in agreement with what has previously been observed after intravenous administration. The plasma concentrations of the 13-hydroxy metabolites did not exceed 30 ng ml−1. The AUC values of these metabolites were on average 20% of the AUC values of the intact drugs.Keywords
This publication has 23 references indexed in Scilit:
- Intrahepatic and intravenous administration of adriamycin—A Comparative pharmacokinetic study in patients with malignant liver tumoursMedical Oncology and Tumor Pharmacotherapy, 1985
- Liquid chromatography in anticancer drug research with special reference to anthraquinone glycosidesJournal of Pharmaceutical and Biomedical Analysis, 1984
- CROSSOVER STUDY OF PHARMACOKINETICS AND HEMATOLOGICAL TOXICITY OF 4'-EPI-DOXORUBICIN AND DOXORUBICIN IN CANCER-PATIENTS1984
- Pharmacokinetics of 4′-epi-doxorubicin in manInvestigational New Drugs, 1983
- PHARMACOKINETIC STUDIES OF 4'-EPI-DOXORUBICIN IN CANCER-PATIENTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION AND WITH HEPATIC METASTASES1982
- Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: Clinical and pharmacokinetic aspectsCancer, 1981
- Distribution of adriamycin in cancer patients. Tissue uptakes, plasma concentration after IV and hepatic IA administrationCancer, 1980
- Intraarterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma.A clinical and pharmacology reportCancer, 1978
- CLINICAL-PHARMACOLOGICAL EVALUATION OF HEPATIC ARTERIAL INFUSIONS OF 5-FLUORO-2'-DEOXYURIDINE AND 5-FLUOROURACIL1978
- Adriamycin metabolism in man. Evidence from urinary metabolites.Drug Metabolism and Disposition, 1976